Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Nov;25(6):739-740.
doi: 10.1007/s40256-025-00763-8. Epub 2025 Sep 10.

Rhythm, Risk, and Responsibility: Assessing the Safety of Testosterone Replacement in Aging Men with Androgen Deficiency

Caique M P Ternes  1   2   3
Affiliations
Editorial

Rhythm, Risk, and Responsibility: Assessing the Safety of Testosterone Replacement in Aging Men with Androgen Deficiency

Caique M P Ternes. Am J Cardiovasc Drugs. 2025 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: No external funding was used in the preparation of this Commentary. Conflict of interest: Caique M.P. Ternes declares no potential conflicts of interest that might be relevant to the contents of this Commentary. Data availability statement: Data sharing is not applicable to this Commentary, as no datasets were generated for it. Ethics approval: Not applicable. Code availability: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable. Author contributions: Caique M.P. Ternes is responsible for writing and editing this Commentary.

Comment on

References

    1. Braga MAP, Rivera A, Marinheiro G, et al. Long-term cardiovascular safety of testosterone-replacement therapy in middle-aged and older men: a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs. 2025. https://doi.org/10.1007/s40256-025-00737-w . - DOI - PubMed
    1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423–32. https://doi.org/10.1016/j.juro.2018.03.115 . - DOI - PubMed
    1. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107–17. https://doi.org/10.1056/NEJMoa2215025 . - DOI - PubMed
    1. Wittert G, Bracken K, Robledo KP, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9(1):32–45. https://doi.org/10.1016/S2213-8587(20)30367-3 . - DOI - PubMed
    1. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611–24. https://doi.org/10.1056/NEJMoa1506119 . - DOI - PubMed - PMC

LinkOut - more resources